Analysts Viewpoint
Chief Executive Officer Zanganeh Mahkam acquire 54,321 shares of Summit Therapeutics Inc [SMMT]
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Summit Therapeutics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.